Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
出版年份 2014 全文链接
标题
Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 110, Issue 6, Pages 1472-1480
出版商
Springer Nature
发表日期
2014-02-21
DOI
10.1038/bjc.2014.79
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transcriptional Control by NF-κB: Elongation in Focus
- (2013) Gil Diamant et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
- (2013) S. Ithimakin et al. CANCER RESEARCH
- Gamma-irradiation induces HER-2/neuoverexpression in breast cancer cell lines and sensitivity to treatment with trastuzumab
- (2013) Ioannis F. Voutsas et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer
- (2012) M. S. N. Mohd Sharial et al. ANNALS OF ONCOLOGY
- HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
- (2012) N. Duru et al. CLINICAL CANCER RESEARCH
- Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma
- (2012) Ana Markovic et al. Expert Review of Anticancer Therapy
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer
- (2012) Anna R. Kwilas Frontiers in Oncology
- Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines
- (2011) D. M. Collins et al. ANNALS OF ONCOLOGY
- Activity and resistance of trastuzumab according to different clinical settings
- (2011) Elda Tagliabue et al. CANCER TREATMENT REVIEWS
- Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- (2011) J. W. Friedberg Hematology-American Society of Hematology Education Program
- Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
- (2010) Olivier Gavet et al. DEVELOPMENTAL CELL
- HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells
- (2010) R Shimizu et al. LEUKEMIA
- Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited
- (2010) Frank Pajonk et al. STEM CELLS
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- Monoclonal antibodies for cancer immunotherapy
- (2009) Louis M Weiner et al. LANCET
- Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
- (2008) Alessandra Beano et al. Journal of Translational Medicine
- Refinement of the Dichlorofluorescein Assay for Flow Cytometric Measurement of Reactive Oxygen Species in Irradiated and Bystander Cell Populations
- (2008) Kurt Hafer et al. RADIATION RESEARCH
- NF-κB-MediatedHER2Overexpression inRadiation-Adaptive Resistance
- (2008) Ning Cao et al. RADIATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started